MEDIPURE ANNOUNCES DIRECTOR OF OPERATIONS FOR CROATIAN SUBSIDIARY
Vancouver, BC – October 29, 2018: Medipure Pharmaceuticals Inc., a biopharmaceutical incubator committed to discovering and developing proprietary endocannabinoid system-based prescription drugs for targeted diseases by regulating specific molecular mechanisms, today announced the appointment of Dr. Dubravko Kičić as Director of Operations for its Croatian subsidiary.